NCT02539823View on ClinicalTrials.gov

Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 24, 2017

Study Completion Date

May 24, 2017

Conditions
Opiate Addiction
Interventions
DRUG

CBD 400 mg

Subjects in Arm CBD 400 mg will receive 400mg of Cannabidiol in each of the three test sessions

DRUG

CBD 800 mg

Subjects in Arm CBD 800 mg will receive 800mg of Cannabidiol in each of the three test sessions

DRUG

Control (placebo)

Subjects will receive a harmless, inactive solution to compare and validate the results of the other arms of the study

Trial Locations (1)

10003

Mount Sinai Beth Israel, New York

Sponsors

Collaborators (1)

Jazz Pharmaceuticals
All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Hurd,Yasmin, Ph.D.

INDIV